GlassScriptPhysician profile
James K Owusu
NPI 1174372221
$845.99
in general payments reported to CMS, 2019-2025
17 companies · $846 in 2025
The $846 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $117.16 | 2025 | |
| Abbvie INC. | $114.50 | 2025 | |
| Amgen INC. | $97.56 | 2025 | Evenity, Repatha, Otezla |
| Lilly USA, LLC | $75.79 | 2025 | Mounjaro, Zepbound, Kisunla |
| Glaxosmithkline, LLC. | $73.69 | 2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $66.01 | 2025 | Farxiga, Airsupra |
| Pfizer INC. | $62.57 | 2025 | |
| Novo Nordisk INC | $52.83 | 2025 | Rybelsus, Ozempic |
| Csl Behring | $26.08 | 2025 | Andembry |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.11 | 2025 | Caplyta |
| Exact Sciences Corporation | $23.36 | 2025 | The Cologuard Plus Collection Kit |
| Sanofi Pasteur INC. | $20.77 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.19 | 2025 | Jardiance |
| Indivior INC. | $19.52 | 2025 | Sublocade |
| Sumitomo Pharma America, INC. | $18.56 | 2025 | Gemtesa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $17.17 | 2025 | Auvelity |
| Merck Sharp & Dohme LLC | $15.12 | 2025 | Rotateq, Vaxneuvance, Vaxelis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Owusu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.